LIMNW (STOCKS)

    Liminatus Pharma, Inc. Warrants

    Change: —
    Prev close: —
    Company Information
    Exchange
    XNAS
    Sector
    Industry
    CEO
    Asset Type
    stocks
    Website
    Fundamentals
    Market Cap
    Employees
    P/E (TTM)
    P/B (TTM)
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Revenues $0.00
    Nonoperating Income/Loss -$7.20M
    Operating Expenses $3.80M
    Operating Income/Loss -$3.80M
    Income/Loss From Continuing Operations After Tax -$11.00M
    Income/Loss From Continuing Operations Before Tax -$11.00M
    Net Income/Loss -$11.00M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$11.00M
    Net Income/Loss Available To Common Stockholders, Basic -$11.00M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$0.44
    Diluted Earnings Per Share -$0.44
    Basic Average Shares 87,424,154
    Diluted Average Shares 87,424,154
    Assets $2.79M
    Current Assets $2.78M
    Noncurrent Assets $11.70K
    Fixed Assets $11.70K
    Liabilities $2.92M
    Current Liabilities $2.89M
    Noncurrent Liabilities $33.42K
    Equity -$132.60K
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent -$132.60K
    Liabilities And Equity $2.79M
    Net Cash Flow From Operating Activities -$11.82M
    Net Cash Flow From Operating Activities, Continuing -$11.82M
    Net Cash Flow From Investing Activities -$1.78M
    Net Cash Flow From Investing Activities, Continuing -$1.78M
    Net Cash Flow From Financing Activities $13.91M
    Net Cash Flow From Financing Activities, Continuing $13.91M
    Net Cash Flow $302.73K
    Net Cash Flow, Continuing $302.73K
    Comprehensive Income/Loss -$11.00M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$11.00M
    Other Comprehensive Income/Loss $0.00